Is Comprehensive Genomic Profiling Ready for Prime Time?
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Category: Meetings
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
When Abigail Johnston’s first child entered preschool six years ago, a vigilant pediatrician recommended an unusual strategy for minimizing...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...